Summary

The global congestive heart failure drugs market size reached USD 9.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24.5 Billion by 2033, exhibiting a growth rate (CAGR) of 10.62% during 2025-2033. The rising prevalence of obesity and cardiovascular problems, increasing geriatric population and unhealthy dietary habits represent some of the key factors driving the market.

Congestive heart failure is a medical condition that affects the pumping ability of the heart muscle. It is generally caused by hypertension, coronary artery disease, diabetes, obesity, and excessive alcohol consumption. Its symptoms include shortness of breath while lying down, weakness, fatigue, swelling in the abdomen, feet, and ankles, frequent urination at night, nausea, and difficulty in concentration. It can be prevented by maintaining a healthy weight, staying physically active, and controlling blood pressure and glycemic levels. Besides this, it is controlled using various prescribed drugs that help prevent blood clots, expand blood vessels, strengthen the contractions of the heart, and improve heart functioning. At present, ACE inhibitors, vasodilators, digitalis glycosides, diuretics, and beta-blockers are some of the most prescribed congestive heart failure drugs. Amongst these, ACE inhibitors prevent the formation of angiotensin, which causes blood vessels to constrict, and beta blockers block the actions of certain chemicals.

Presently, the increasing global geriatric population, which is highly susceptible to diabetes and chronic cardiovascular diseases, represents one of the major factors positively influencing the market. In addition, excessive smoking and drinking of alcoholic beverages, coupled with unhealthy dietary habits of individuals, increases the risks of heart problems, which is catalyzing the demand for congestive heart failure drugs across the globe. This, coupled with the rising occurrence of heart problems due to obesity and lack of physical activity, is currently strengthening the growth of the market. Furthermore, the increasing awareness among individuals about the benefits of early diagnosis and treatment of heart disease is creating a positive outlook for the market. Apart from this, the escalating demand for effective drugs and treatment and their approval from authorized agencies offer lucrative growth opportunities to the leading market players. Moreover, initiatives undertaken by governments of various countries to improve healthcare infrastructure and provide optimal care to patients are contributing to the growth of the market. Additionally, the expansion of pharmacies in hospitals and residential areas and the burgeoning e-commerce industry providing easy availability of medicines at affordable rates and the facility of secured online payment methods are expected to propel the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global congestive heart failure drugs market, along with forecasts at the global, regional, and country level from 2025-2033. Our report has categorized the market based on drug class, route of administration, and distribution channel.

Drug Class Insights:

ACE Inhibitors
Angiotensin 2 Receptor Blockers
Beta Blockers
Diuretics
Aldosterone Antagonists
Inotropes
Others

The report has also provided a detailed breakup and analysis of the congestive heart failure drugs market based on the drug class. This includes ACE inhibitors, angiotensin 2 receptor blockers, beta blockers, diuretics, aldosterone antagonists, inotropes, and others. According to the report, ACE inhibitors represented the largest segment.

Route of Administration Insights:

Oral
Intravenous

A detailed breakup and analysis of the congestive heart failure drugs market based on the route of administration has also been provided in the report. This includes oral and intravenous. According to the report, the oral route of administration accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

A detailed breakup and analysis of the congestive heart failure drugs market based on the route of administration has also been provided in the report. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies accounted for the largest market share.

Regional Insights:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (The United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. According to the report, North America was the largest market for congestive heart failure drugs. Some of the factors driving the North America market included the development of healthcare infrastructure, increasing cases of heart failure and the easy availability of technologically advanced devices and innovative drugs.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global congestive heart failure drugs market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn Ag & Co. KG), Novartis AG, etc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. How big is the global congestive heart failure drugs market?
2. What is the expected growth rate of the global congestive heart failure drugs market during 2025-2033?
3. What are the key factors driving the global congestive heart failure drugs market?
4. What has been the impact of COVID-19 on the global congestive heart failure drugs market?
5. What is the breakup of the global congestive heart failure drugs market based on the drug class?
6. What is the breakup of the global congestive heart failure drugs market based on the route of administration?
7. What is the breakup of the global congestive heart failure drugs market based on the distribution channel?
8. What are the key regions in the global congestive heart failure drugs market?
9. Who are the key players/companies in the global congestive heart failure drugs market?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Congestive Heart Failure Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 ACE Inhibitors
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Angiotensin 2 Receptor Blockers
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Beta Blockers
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Diuretics
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Aldosterone Antagonists
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Inotropes
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Intravenous
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AstraZeneca plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Bayer AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn Ag & Co. KG)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Novartis AG
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

List of Figures

​Figure 1: Global: Congestive Heart Failure Drugs Market: Major Drivers and Challenges
Figure 2: Global: Congestive Heart Failure Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Congestive Heart Failure Drugs Market: Breakup by Drug Class (in %), 2024
Figure 5: Global: Congestive Heart Failure Drugs Market: Breakup by Route of Administration (in %), 2024
Figure 6: Global: Congestive Heart Failure Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Congestive Heart Failure Drugs Market: Breakup by Region (in %), 2024
Figure 8: Global: Congestive Heart Failure Drugs (ACE Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Congestive Heart Failure Drugs (ACE Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Congestive Heart Failure Drugs (Angiotensin 2 Receptor Blockers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Congestive Heart Failure Drugs (Angiotensin 2 Receptor Blockers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Congestive Heart Failure Drugs (Beta Blockers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Congestive Heart Failure Drugs (Beta Blockers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Congestive Heart Failure Drugs (Diuretics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Congestive Heart Failure Drugs (Diuretics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Congestive Heart Failure Drugs (Aldosterone Antagonists) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Congestive Heart Failure Drugs (Aldosterone Antagonists) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Congestive Heart Failure Drugs (Inotropes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Congestive Heart Failure Drugs (Inotropes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Congestive Heart Failure Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Congestive Heart Failure Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Congestive Heart Failure Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Congestive Heart Failure Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Congestive Heart Failure Drugs (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Congestive Heart Failure Drugs (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Congestive Heart Failure Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Congestive Heart Failure Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Congestive Heart Failure Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Congestive Heart Failure Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Congestive Heart Failure Drugs (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Congestive Heart Failure Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: North America: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: North America: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: United States: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: United States: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Canada: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Canada: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Asia-Pacific: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Asia-Pacific: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: China: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: China: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Japan: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Japan: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: India: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: India: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: South Korea: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: South Korea: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Australia: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Australia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Indonesia: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Indonesia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Europe: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Europe: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Germany: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Germany: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: France: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: France: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: United Kingdom: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: United Kingdom: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Italy: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Italy: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Spain: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Spain: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Russia: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Russia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Latin America: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Latin America: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Brazil: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Brazil: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Mexico: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Mexico: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Middle East and Africa: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Middle East and Africa: Congestive Heart Failure Drugs Market: Breakup by Country (in %), 2024
Figure 80: Middle East and Africa: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Global: Congestive Heart Failure Drugs Industry: Drivers, Restraints, and Opportunities
Figure 82: Global: Congestive Heart Failure Drugs Industry: Value Chain Analysis
Figure 83: Global: Congestive Heart Failure Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Congestive Heart Failure Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 3: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 4: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 5: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Congestive Heart Failure Drugs Market: Competitive Structure
Table 7: Global: Congestive Heart Failure Drugs Market: Key Players